Anika Therapeutics, Inc. Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares
Anika Therapeutics, Inc. (ANIK) reported Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares of 500.00 thousand shares for the 6-month period ending 2013-06-30, per its 10-Q filed 2013-08-06.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares · last filed 2013-08-06
- Anika Therapeutics, Inc. incremental common shares attributable to dilutive effect of contingently issuable shares for the quarter ending 2013-03-31 was 500.00K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares 3 month | Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares 6 month |
|---|---|---|
| 2013-06-30 | 500.00K shares 10-Q · filed 2013-08-06 | |
| 2013-03-31 | 500.00K shares 10-Q · filed 2013-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |